Is ArcBest's (ARCB) Buyback Strategy Enough to Offset Pressure From Softer Earnings?

• ArcBest Corporation recently reported results for the second quarter and first half of 2025, showing year-over-year declines in sales to US$1,022.26 million and net income to US$25.81 million for the quarter, alongside completion of a share buyback covering nearly 27% of total shares since 2003.
• This demonstrates how operational and profitability pressures have persisted, even as the company continued to repurchase shares in support of shareholder value.
• We'll explore how ArcBest’s softer quarterly results and ongoing buyback activity influence its current investment narrative and future outlook.

These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

ArcBest Investment Narrative Recap

To be a shareholder in ArcBest right now, you need to believe that investments in new logistics solutions, technology adoption, and growing the LTL customer pipeline will eventually offset ongoing freight market pressures and margin headwinds. The latest earnings report, which showed lower sales and profits for both the quarter and half-year, reinforces that the softness in industrial activity remains the most important near-term challenge, while also leaving the company’s biggest risk, ongoing rate pressure and muted shipment volumes, essentially unchanged.

Among the most relevant recent announcements, ArcBest completed another tranche of share buybacks, bringing total repurchases since 2003 to nearly 27% of outstanding shares. While this activity may support longer-term per-share value, it does not materially lessen the near-term operational challenges driven by rate competition and elevated labor costs.

In contrast, investors should also be mindful of persistent industry overcapacity and the potential for further pricing pressure that could …

Read the full narrative on ArcBest (it's free!)

ArcBest's outlook projects $4.6 billion in revenue and $146.4 million in earnings by 2028. This assumes a 3.9% annual revenue growth rate but a decrease in earnings of $11.9 million from the current $158.3 million.

Uncover how ArcBest's forecasts yield a $89.17 fair value, a 23% upside to its current price.

Exploring Other Perspectives

Community members from Simply Wall St have fair value estimates for ArcBest ranging from US$73.91 to US$89.17, based on two separate forecasts. While investors see opportunity, many remain watchful as industry overcapacity and rate softness remain key risks worth exploring further in your own research.

Explore 2 other fair value estimates on ArcBest - why the stock might be worth as much as 23% more than the current price!

Build Your Own ArcBest Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your ArcBest research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free ArcBest research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate ArcBest's overall financial health at a glance.

Searching For A Fresh Perspective?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
• The end of cancer? These 26 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com